Spire Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5K | Sell |
121
-47
| -28% | -$10.3K | ﹤0.01% | 1412 |
|
|
2025
Q1 | $37.6K | Sell |
168
-92
| -35% | -$20.6K | ﹤0.01% | 1387 |
|
|
2024
Q4 | $85.2K | Sell |
260
-4,125
| -94% | -$1.35M | ﹤0.01% | 1093 |
|
|
2024
Q3 | $1.32M | Sell |
4,385
-8,998
| -67% | -$2.7M | 0.04% | 313 |
|
|
2024
Q2 | $4.41M | Buy |
13,383
+13,253
| +10,195% | +$4.37M | 0.16% | 137 |
|
|
2024
Q1 | $51.4K | Buy |
130
+14
| +12% | +$5.54K | ﹤0.01% | 1205 |
|
|
2023
Q4 | $39.8K | Sell |
116
-12
| -9% | -$4.11K | ﹤0.01% | 1285 |
|
|
2023
Q3 | $48K | Sell |
128
-43
| -25% | -$16.1K | ﹤0.01% | 1185 |
|
|
2023
Q2 | $65.4K | Sell |
171
-71
| -29% | -$27.2K | ﹤0.01% | 1100 |
|
|
2023
Q1 | $83.8K | Sell |
242
-29
| -11% | -$10K | ﹤0.01% | 1019 |
|
|
2022
Q4 | $64K | Buy |
271
+14
| +5% | +$3.31K | ﹤0.01% | 903 |
|
|
2022
Q3 | $63K | Buy |
257
+2
| +0.8% | +$490 | ﹤0.01% | 870 |
|
|
2022
Q2 | $77K | Sell |
255
-17
| -6% | -$5.13K | ﹤0.01% | 1130 |
|
|
2022
Q1 | $112K | Sell |
272
-21
| -7% | -$8.65K | ﹤0.01% | 1125 |
|
|
2021
Q4 | $138K | Buy |
293
+1
| +0.3% | +$471 | ﹤0.01% | 1273 |
|
|
2021
Q3 | $124K | Buy |
292
+2
| +0.7% | +$849 | ﹤0.01% | 1119 |
|
|
2021
Q2 | $104K | Sell |
290
-16
| -5% | -$5.74K | ﹤0.01% | 1170 |
|
|
2021
Q1 | $86K | Buy |
+306
| New | +$86K | ﹤0.01% | 1460 |
|